A prospective study of oral 5-aminolevulinic acid to prevent adverse events in patients with localized prostate cancer undergoing low-dose-rate brachytherapy: Protocol of the AMBER study

Autor: Miyake, Makito, Tanaka, Nobumichi, Asakawa, Isao, Yamaki, Kaori, Inoue, Takashi, Suzuki, Shota, Hori, Shunta, Nakai, Yasushi, Anai, Satoshi, Torimoto, Kazumasa, Toritsuka, Michihiro, Nakagawa, Hitoshi, Tsukamoto, Shinji, Fujii, Tomomi, Ohbayashi, Chiho, Hasegawa, Masatoshi, Kasahara, Masato, Fujimoto, Kiyohide
Zdroj: In Contemporary Clinical Trials Communications September 2020 19
Databáze: ScienceDirect